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CagA is a major disease-associated factor injected by the gastric pathogen Helicobacter pylori. In this issue,
Hayashi et al. (2012) report the crystallographic structure of the CagA N terminus (residues 24–876) at 3.19 A˚
resolution. This study revealed three distinct domains, giving novel insights into intramolecular and intermo-
lecular protein and phosphatidylserine interactions.One of the most intensely investigated
bacterial virulence factors is the CagA
protein of the gastric pathogen and type-I
carcinogenHelicobacter pylori. CagAwas
originally discovered about 20 years ago
and then recognized as a major disease-
associated factor (reviewed by Hata-
keyama, 2008; Backert et al., 2010).
CagA shares no sequence homology to
any known bacterial or eukaryotic pro-
tein and varies in size from about
125 kDa to145 kDa. CagA is the only
known effector protein translocated by
the type IV secretion system (T4SS)
characteristic of highly virulent H. pylori
strains. Intensive research over two
decades has revealed some insights into
how CagA acts in gastric epithelial cells.
A direct causal link between CagA and
gastric pathogenesis was proven by
H. pylori infection of Mongolian gerbils
and transgenic mice expressing CagA.
Studies on the mechanism of CagA injec-
tion have indicated that it requires various
T4SS proteins (CagA, CagI, CagL, and
CagY) interacting with a host cell re-
ceptor, integrin-b1 (Kwok et al., 2007;
Jime´nez-Soto et al., 2009), as well as
CagA targeting phosphatidylserine (Mur-
ata-Kamiya et al., 2010). Upon delivery
into host target cells, CagA is phosphor-
ylated in the so-called EPIYA motifs
by Src and Abl family kinases (Mueller
et al., 2012). CagA can interact with itself
and >20 reported cellular binding part-
ners, including tyrosine phosphatase
SHP2 and partitioning defective-1 (PAR1)
kinase, to hijack a wide array of signaling
pathways involved in disease develop-
ment (Hatakeyama, 2008; Nesic et al.,
2010; Backert et al., 2010). Other earlier
data indicated that CagA may consist of
two main structural domains comprisingthe 100 kDa N terminus and 35 kDa
C terminus, respectively (Moese et al.,
2001; Bagnoli et al., 2005). However,
detailed functional studies have been so
far hampered by the lack of structural
data for full-length CagA (CagAFL).
In this issue of Cell Host & Microbe,
Hayashi et al. (2012) report a structure-
function analysis based on CagA-domain
and tertiary structural data. CagA of strain
26695 from a gastritis patient was chosen
as the model. In a first set of experiments,
the authors characterized N-terminal (re-
sidues 1–876) and C-terminal (residues
877–1186) fragments (CagA1-876 and
CagA877-1186) after cleavage by V8 pro-
tease. C-terminal CagA contains the
EPIYA and CagA multimerization (CM)
motifs, which act as binding sites for
SHP2 and PAR1, respectively (Hata-
keyama, 2008; Mueller et al., 2012; Nesic
et al., 2010). This CagA part exhibits scaf-
fold/hub functions, which are responsible
for the morphogenetic activity of CagA
observed in transfected or infected gas-
tric epithelial cells known as the hum-
mingbird or elongation phenotype. Vari-
ous immunoprecipitation and surface
plasmon resonance spectroscopy exper-
iments showed that CagA877-1186 binds
PAR1, but with one order of magnitude
less than CagAFL. Microinjection of
CagA877-1186 confirmed its phenotype-
inducing capacity, although the efficiency
was also less as compared to CagAFL.
Therefore, purified CagA877-1186 exhibits
a substantial but attenuated level of CagA
activity. To study the physicochemical
properties of C-terminal CagA, 1H-NMR
analyses of recombinant CagA877-1186
were performed. The NMR data suggest
that CagA877-1186 has no high-order struc-
ture at all. In agreement with a previousCell Host & Microstudy (Nesic et al., 2010), these results
indicate that the C terminus is intrinsically
disordered and therefore lacks a solid
structure. Interestingly, Bagnoli and co-
workers noticed that N-terminal and
C-terminal CagA cooperate, resulting in
enhancedmorphogenetic activity (Bagnoli
et al., 2005). But how do these domains
interact and influence each other? Since
N-terminal CagA1-876 did not directly bind
toPAR1, thepresenceof a functional inter-
play between the N and C terminus was
proposed, and this may enhance the in-
teraction of CagA and PAR1. Based on
mutagenesis and binding experiments,
the authors defined residues 782–820 as
N-terminal binding sequence (NBS) and
residues 998–1038 as C-terminal bind-
ing sequence (CBS) (Figure 1A). Whereas
CBS contained neither EPIYA nor CM
sequences, a CagA mutant lacking CBS
(CagAD998-1038) revealed significantly
attenuated SHP2 binding and impaired
cell elongation, giving additional support
for the idea of intramolecular interactions
in enhancing the biological activities of
CagA. Given that CagA-PAR1 interaction
is already known tobe important for robust
CagA-SHP2 interaction (Hatakeyama,
2008), the impaired CagA activity was
most likely due to reduced CagA-PAR1
binding in the absence of N-terminal/
C-terminal interactions within CagA.
In the following set of experiments,
recombinant CagA was subjected to
crystallizationexperiments.Unfortunately,
CagAFL crystals were not observed, prob-
ably due to the unstructured properties of
CagA’s C terminus. The structure of
CagA261-829 was first determined, albeit
at relatively low resolution (3.19 A˚). Using
the CagA261-829 structure as a template,
the structure of CagA1-876 was then alsobe 12, July 19, 2012 ª2012 Elsevier Inc. 3
Figure 1. Structure of theCagAN-Terminal Region andModeling of the ThreeDomains in the
Protein
(A) Schematic diagram of CagA from the TIGR strain 26695 including the carboxyl-terminal EPIYA phos-
phorylation sites (A, B, C) and two CM motifs. The three domains (I–III) of N-terminal CagA1-876 as well as
the interacting NBS (residues 782–820) and CBS (residues 998–1038) sequences are also indicated.
(B) Ribbon diagrams (top) and models (bottom) of the crystal structure derived from N-terminal CagA1-876
fragment as reported by Hayashi et al. (2012) in this issue ofCell Host &Microbe. Front and back views are
shown. Domain-I (blue) corresponds to residues 24–221, Domain-II (red) to residues 303–644, and
Domain-III (yellow) to residues 645–824. Larger unstructured stretches (residues 1–23, residues 222–
303, and residues 825–876) were excluded from the domains. The pictures in (B) were kindly provided
Dr. Masanori Hatakeyama (Tokyo University).
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ever, were detected for residues 825–
876, suggesting that this region is structur-
ally disordered like the C terminus. It was
therefore concluded that the entire CagA
protein comprises a mainly structured N
terminus (residues 1–829) and an intrinsi-
cally disordered C-terminal domain (830–
1186). Overall, the structure of CagA1-829
revealed a square plate-like shape con-
sisting of three structurally distinct do-
mains, named I–III (Figures 1A and 1B),
including short disordered stretches (resi-
dues 222–302, 479–488, and 510–536)4 Cell Host & Microbe 12, July 19, 2012 ª201without electron density. Domain-I had
a small interacting surface region with
Domain-II, but not Domain-III. Domain-II
and Domain-III were connected via a -
flexible helix (a19) and exhibit an ‘‘N-like’’
dimodular shape, together forming a
proposed rigid core element of CagA
(Figure 1B).
Packing analysis of the CagA1-876
structure showed not only intramolecular
domain interactions but also intermo-
lecular interactions to form N-terminal
dimers. Helices a22 and a23 of two neigh-
boring CagA fragments revealed hydro-2 Elsevier Inc.phobic interactions by forming an in-
termolecular four-helix bundle in these
dimers. However, some in vitro binding
studies argued against the N-terminal
dimerization model in solution. Together
with the small interaction surface of the
dimer seen, the authors favored the idea
that the N-terminal CagA dimerization
was due to crystal packing. However, it
was also noticed that nine hydrophobic
residues in NBS, which form the hydro-
phobic interaction interface, were highly
conserved in the NBS-related CBS. This
unexpected finding led them to examine
whether the N-terminal dimerization in-
terface was also utilized for the intramo-
lecular interaction between the N and
C terminus of CagA. Interestingly, this
intramolecular interaction was completely
abolished by L792R or L812R mutation
in NBS, indicating a critical role for
the hydrophobic NBS/CBS interaction in
the association between the N and
C terminus of CagA.
Because CBS is located very close
to the CM region in C-terminal CagA
(Figure 1A), it seemed plausible that the
intramolecular NBS/CBS interaction may
influence recruitment of PAR1. Impor-
tantly, the kinetics of surface plasmon
resonance analysis for PAR1 binding to
CagAL812R were remarkably different
from those obtained using wild-type
CagA (CagAWT). PAR1 associated with
and dissociated from CagAL812R more
rapidly than CagAWT. These results indi-
cate that turnover of the CagA-PAR1
complex was accelerated in the absence
of intramolecular NBS/CBS interactions.
Since PAR1-mediated tethering of two
CagA proteins via the CM sequence can
enhance CagA-SHP2 complex formation
(Hatakeyama, 2008), elevated turnover
of the CagA-PAR1 complex was then
shown to influence CagA-SHP2 bind-
ing. In fact, CagA mutants with abro-
gated intramolecular NBS/CBS interac-
tion also revealed reduced SHP2 binding
and decreased hummingbird/elongation
phenotype in gastric epithelial cells.
These observations collectively indicate
that, upon intramolecular NBS/CBS inter-
action, a substantial portion of the intrinsi-
cally disordered C-terminal CagA adopts
a change in secondary structure. Adap-
tive folding induced within or near the
CM sequence of C-terminal CagA may
therefore underlie reduced turnover of
the CagA-PAR1 complex in response to
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which potentiates the pathogenic scaf-
fold/hub function of CagA.
Finally, the authors investigated CagA-
phosphatidylserine (PS) interactions, as
this influences the transport of CagA and
its localization to the inner plasma mem-
brane (Murata-Kamiya et al., 2010). Two
arginines (R624 and R626), crucial for
the CagA-PS interaction, were located in
the a18 helix of Domain-II. Structural
and mutational analyses identified that
R624 and R626 form a basic amino acid
cluster with several lysine residues (posi-
tion 613, 614, 617, 621, 625, 631, and
635), providing a positive electrostatic
surface potential important for CagA-PS
docking. The molecular orientation of
delivered CagA relative to the plasma
membrane was also deduced from these
studies.
Taken together, the above findings pro-
vide a comprehensive structural picture of
the N terminus of CagA. The tertiary struc-
ture of CagA1-876 is unique, with no
homologous other structure yet reported.
Structure-function data reported here
clearly indicate that the N terminus mayserve as a regulatory element for the
C terminus. However, the current
CagA1-876 structure still has gaps due to
resolution problems. Thus, more efforts
are necessary to obtain high-resolution
crystal structures of the N and C terminus
and CagAFL. It will be also highly inter-
esting to investigate in future studies
how other known interaction partners in-
cluding RUNX3, integrin-b1, apoptosis-
stimulating protein of p53 (ASPP2),
CagF, and others interact with the indi-
vidual segments of CagA1-876 and influ-
ence its function. Efforts to cocrystallize
CagA with these or other interaction part-
ners may be helpful here. The present
studies of Hayashi et al. (2012) provide
important knowledge for the under-
standing of H. pylori-triggered pathology
and developing inhibitors for more effec-
tive new therapy against this important
pathogen.REFERENCES
Backert, S., Tegtmeyer, N., and Selbach, M.
(2010). Helicobacter 15, 163–176.Cell Host & MicroBagnoli, F., Buti, L., Tompkins, L., Covacci, A., and
Amieva, M.R. (2005). Proc. Natl. Acad. Sci. USA
102, 16339–16344.
Hatakeyama, M. (2008). Curr. Opin. Microbiol. 11,
30–37.
Hayashi, T., Senda, M., Morohashi, H., Higashi, H.,
Horio, M., Kashiba, Y., Nagase, L., Sasaya, D.,
Shimizu, T., Venugopalan, N., et al. (2012). Cell
Host Microbe 12, this issue, 20–33.
Jime´nez-Soto, L.F., Kutter, S., Sewald, X., Ertl, C.,
Weiss, E., Kapp, U., Rohde, M., Pirch, T., Jung, K.,
Retta, S.F., et al. (2009). PLoS Pathog. 5,
e1000684.
Kwok, T., Zabler, D., Urman, S., Rohde, M., Hartig,
R., Wessler, S., Misselwitz, R., Berger, J., Sewald,
N., Ko¨nig, W., and Backert, S. (2007). Nature 449,
862–866.
Moese, S., Selbach, M., Zimny-Arndt, U., Jungblut,
P.R., Meyer, T.F., and Backert, S. (2001). Pro-
teomics 1, 618–629.
Mueller, D., Tegtmeyer, N., Brandt, S., Yamaoka,
Y., De Poire, E., Sgouras, D., Wessler, S., Torres,
J., Smolka, A., and Backert, S. (2012). J. Clin.
Invest. 122, 1553–1566.
Murata-Kamiya, N., Kikuchi, K., Hayashi, T., Higa-
shi, H., and Hatakeyama, M. (2010). Cell Host
Microbe 7, 399–411.
Nesic, D., Miller, M.C., Quinkert, Z.T., Stein, M.,
Chait, B.T., and Stebbins, C.E. (2010). Nat. Struct.
Mol. Biol. 17, 130–132.NETs Tangle with HIVCraig N. Jenne1,2 and Paul Kubes1,3,*
1Calvin, Phoebe & Joan Snyder Institute for Chronic Diseases
2Department of Critical Care Medicine
3Department of Physiology and Pharmacology
University of Calgary, Calgary, Alberta, Canada T2N 4N1
*Correspondence: pkubes@ucalgary.ca
http://dx.doi.org/10.1016/j.chom.2012.07.002
Neutrophil extracellular traps (NETs) are comprised of extracellular DNA coated in cytotoxic proteins capable
of ensnaring and killing bacteria. Saitoh et al. (2012) expand our understanding of NETs into antiviral immunity
by demonstrating that HIV induces the formation of NETs, which can bind and neutralize viral particles.Neutrophils are the foot soldiers of the
innate immune response. These cells are
often the first to respond to pathogens,
arriving rapidly and deploying a vast array
of antimicrobial agents in an effort to
control the early phases of infection. This
arsenal of effector mechanisms include
the ability to phagocytose pathogens
and the release of large numbers of anti-microbial peptides, cytokines, and reac-
tive oxygen species (ROS). More recently,
a novel effector mechanism has been
described whereby in response to a path-
ogen, the nuclear DNA of the neutrophil
decondenses and is released from the
cell to form a large sticky web. These
Neutrophil extracellular traps (NETs) are
decorated with histones—and antimicro-bial proteins such as neutrophil elastase,
myeloperoxidase (MPO), and a-defensin
(Brinkmann et al., 2004). Furthermore,
NETs have been demonstrated to both
ensnare and directly kill a number of
different bacteria.
Although viral infection has classically
been studied in the context of the
adaptive immune response, a significantbe 12, July 19, 2012 ª2012 Elsevier Inc. 5
